United States · 
Who invested in Strategikon Pharma?
Strategikon Pharma's investors include Alumni Ventures, Tech Coast Angels, Wing Venture Capital, Golden Seeds and Osage Venture Partners.
United States · Funded startup
Who invested in Strategikon Pharma
Funding summaryUpdated 26 Oct 2026
$2.3Mraised across 1 round since 2025, from 1 source
- Latest round
- Debt, $2.3MJun 2025
- Investors
- 5
The rounds
- Jun 2025Debt$2.3M
Source recorded
Founders and team
From Strategikon Pharma's own website: 4 on the team.
- Axel Stael von HolsteinExecutive Vice President, Global Business Development
- Mark WeinsteinChairman of the Board, former CEO BioClinica
- Corsee SandersBiopharma Leader & Consultant; Clinical Biometrics and Operations
- Vincent LepreuxInvestment Director at Debiopharm Innovation Fund
Everyone who backed them
Tech Coast AngelsVC firm1round
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 2 firms list Strategikon Pharma as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Strategikon Pharma
How much has Strategikon Pharma raised?
Strategikon Pharma has raised $2.3M across 1 round since 2025.
When did Strategikon Pharma last raise?
Strategikon Pharma's most recent round was a Debt of $2.3M in Jun 2025.
What was Strategikon Pharma's biggest round?
Its most recent round, $2.3M in Jun 2025, is also its largest on record.
Who backed Strategikon Pharma first?
Strategikon Pharma's first round on record, in Jun 2025, was backed by Alumni Ventures, Tech Coast Angels and Wing Venture Capital and 2 others.
What stage is Strategikon Pharma at?
Strategikon Pharma's latest named round is a Debt, in Jun 2025.
Where is Strategikon Pharma based?
Strategikon Pharma is based in the United States.
Companies like Strategikon Pharma
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.